Published in Am J Hum Genet on June 01, 1999
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet (2001) 4.97
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet (2002) 4.00
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease. Genome Res (2005) 2.61
Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo. PLoS One (2009) 1.67
Signaling by bone morphogenetic proteins directs formation of an ectodermal signaling center that regulates craniofacial development. Dev Biol (2007) 1.20
Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts. J Cell Biochem (2010) 1.17
A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice. Bone Res (2013) 0.94
Prostaglandin E2 signals through PTGER2 to regulate sclerostin expression. PLoS One (2011) 0.92
Localisation of the gene causing diaphyseal dysplasia Camurati-Engelmann to chromosome 19q13. J Med Genet (2000) 0.92
SOST and DKK: Antagonists of LRP Family Signaling as Targets for Treating Bone Disease. J Osteoporos (2010) 0.91
Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia. Hum Genet (2011) 0.84
Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management. Rheumatology (Oxford) (2013) 0.84
Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model. Bone (2015) 0.84
Sclerostin inhibition: a novel therapeutic approach in the treatment of osteoporosis. Int J Womens Health (2015) 0.83
Van Buchem disease: lifetime evolution of radioclinical features. Skeletal Radiol (2003) 0.79
Developments in sclerostin biology: regulation of gene expression, mechanisms of action, and physiological functions. Curr Osteoporos Rep (2014) 0.79
Role and mechanism of action of sclerostin in bone. Bone (2016) 0.78
A Novel Loss-of-Sclerostin Function Mutation in a First Egyptian Family with Sclerosteosis. Biomed Res Int (2015) 0.75
Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet (1984) 28.51
A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (1996) 27.61
Perspectives of identity by descent (IBD) mapping in founder populations. Clin Exp Allergy (1995) 8.16
The clinical features of sclerosteosis. A review of the manifestations in twenty-five affected individuals. Ann Intern Med (1976) 1.63
The syndromic status of sclerosteosis and van Buchem disease. Clin Genet (1984) 1.58
Sclerosteosis. J Med Genet (1988) 1.47
Sclerosteosis: neurogenetic and pathophysiologic analysis of an American kinship. Neurology (1983) 1.47
L1-associated diseases: clinical geneticists divide, molecular geneticists unite. Hum Mol Genet (1997) 1.39
Sclerosteosis. A case report. J Bone Joint Surg Am (1975) 1.31
Hyperostosis corticalis generalisata congenita. J Can Assoc Radiol (1966) 1.23
[Generalized hyperostosis corticalis (dominant transmission) (Worth's type)]. Arch Fr Pediatr (1972) 1.22
Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21. Am J Hum Genet (1998) 1.20
Sclerosteosis: report of a case in a black African man. Clin Genet (1998) 1.12
Two cases of Van Buchem's disease. J Neurol Neurosurg Psychiatry (1982) 1.11
Sclerosteosis in a Spanish male: first report in a person of Mediterranean origin. J Med Genet (1994) 1.11
Van Buchem's disease (hyperostosis corticalis generalisata) Br J Radiol (1976) 1.03
Optimization of microsatellite analysis for genetic mapping. Genomics (1993) 0.93
[Partial empty sella turcica in Van Buchem's disease]. Med Clin (Barc) (1986) 0.93
Van Buchem disease: surgical treatment of the mandible. Ann Plast Surg (1988) 0.93
Van Buchem's disease with classical radiological features and appearances on cranial computed tomography. Br J Radiol (1989) 0.92
[Endosteal hyperostosis with recessive transmission (Van Buchem's disease). A case report]. Recenti Prog Med (1991) 0.91
[Hyperostosis corticalis generalisata (Van Buchem)]. Rev Clin Esp (1985) 0.90
Facial paralysis at the age of 2 months as a first clinical sign of van Buchem disease (endosteal hyperostosis). Eur J Pediatr (1988) 0.89
Van Buchem's disease (hyperostosis corticalis generalisata familiaris). A case report. Br J Oral Surg (1972) 0.88
Autosomal dominant osteosclerosis. Radiology (1977) 0.85
Autosomal dominant endosteal hyperostosis. Report of a Spanish family with neurological involvement. Clin Genet (1987) 0.83
Surgical treatment of van Buchem's disease. J Oral Maxillofac Surg (1985) 0.82
[Van Buchem disease. Study of 2 cases and review of the literature]. An Med Interna (1995) 0.81
Sclerosteosis involving the temporal bone: clinical and radiologic aspects. Am J Otolaryngol (1984) 0.79
[New cases of familial generalized cortical hyperostosis with dominant transmission (Worth's type) (author's transl)]. J Radiol Electrol Med Nucl (1976) 0.78
[Dominant generalized cortical hyperostosis with multiple involvement of the cranial nerves]. Nouv Presse Med (1976) 0.78
Autosomal dominant osteosclerosis. Radiology (1977) 0.78
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet (2000) 6.26
Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med (1991) 6.09
Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med (1999) 5.82
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet (2001) 5.72
Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci U S A (1997) 4.73
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet (2002) 4.00
Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet (2001) 3.77
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol (1994) 3.70
A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat Genet (1993) 3.58
An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci U S A (2001) 3.14
Nonsyndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet (1997) 2.82
Indirect microlaryngostroboscopic surgery. Arch Otolaryngol Head Neck Surg (1992) 2.77
Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. Hum Mol Genet (2000) 2.73
Germline mosaicism and Duchenne muscular dystrophy mutations. Nature (1987) 2.56
Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment. Nat Genet (1998) 2.52
Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet (1992) 2.40
Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Ann Intern Med (1995) 2.39
Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet (1999) 2.23
Identification of a novel genetic locus for familial cardiac myxomas and Carney complex. Circulation (1998) 2.21
The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet (1992) 2.18
Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet (2001) 2.15
Non-syndromic, autosomal-recessive deafness. Clin Genet (2006) 2.08
Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res (1998) 2.06
Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science (1990) 1.92
Osteochondromyxoma of bone: a congenital tumor associated with lentigines and other unusual disorders. Am J Surg Pathol (2001) 1.90
EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet (1999) 1.70
Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment. J Med Genet (2005) 1.69
Assignment of a second locus for multiple exostoses to the pericentromeric region of chromosome 11. Hum Mol Genet (1994) 1.68
Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families. Nature (1987) 1.68
A new family with the Townes-Brocks syndrome. Clin Genet (1988) 1.66
A clinical and molecular overview of the human osteopetroses. Calcif Tissue Int (2005) 1.65
CRASH syndrome: clinical spectrum of corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraparesis and hydrocephalus due to mutations in one single gene, L1. Eur J Hum Genet (1995) 1.64
Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat Genet (1998) 1.63
Mutations in the gene encoding the latency-associated peptide of TGF-beta 1 cause Camurati-Engelmann disease. Nat Genet (2000) 1.63
Mitochondrial deafness. Clin Genet (2007) 1.61
Positional cloning of a gene involved in hereditary multiple exostoses. Hum Mol Genet (1996) 1.58
Estimation of the size of the chromosome 17p11.2 duplication in Charcot-Marie-Tooth neuropathy type 1a (CMT1a). HMSN Collaborative Research Group. J Med Genet (1992) 1.57
L1 knockout mice show dilated ventricles, vermis hypoplasia and impaired exploration patterns. Hum Mol Genet (1998) 1.54
Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum Mol Genet (1999) 1.54
Molecular dissection of a contiguous gene syndrome: localization of the genes involved in the Langer-Giedion syndrome. Hum Mol Genet (1995) 1.51
FMRP is associated to the ribosomes via RNA. Hum Mol Genet (1996) 1.49
Poor outcome in Down syndrome fetuses with cardiac anomalies or growth retardation. Am J Med Genet A (2003) 1.48
SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med (2009) 1.47
A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions. J Med Genet (2004) 1.46
Long-term potentiation in the hippocampus of fragile X knockout mice. Am J Med Genet (1996) 1.45
Is screening for pharyngeal Chlamydia trachomatis warranted in high-risk groups? Int J STD AIDS (2010) 1.44
Genetic factors in non-syndromic congenital heart malformations. Clin Genet (2010) 1.43
Pulmonary metastases: MR imaging with surgical correlation--a prospective study. Radiology (1992) 1.41
Localization of the gene for hyperostosis cranialis interna to chromosome 8p21 with analysis of three candidate genes. Calcif Tissue Int (2013) 1.41
Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses. Am J Hum Genet (1998) 1.39
Two brothers with mental retardation discordant for the fragile-X syndrome. Am J Med Genet (1990) 1.39
L1-associated diseases: clinical geneticists divide, molecular geneticists unite. Hum Mol Genet (1997) 1.39
The human extracellular matrix gene 1 (ECM1): genomic structure, cDNA cloning, expression pattern, and chromosomal localization. Genomics (1997) 1.38
'Trampoline fracture' of the proximal tibia in children: report of 3 cases and review of literature. JBR-BTR (2012) 1.38
Protein kinase A and its role in human neoplasia: the Carney complex paradigm. Endocr Relat Cancer (2004) 1.38
A two-year follow-up study comparing short with long stay in-patient treatment of alcoholics. Br J Psychiatry (1973) 1.37
Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes. Hum Mutat (2000) 1.36
Dynamic mutations hit double figures. Nat Genet (1994) 1.32
Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience (1997) 1.32
Two frequent missense mutations in Pendred syndrome. Hum Mol Genet (1998) 1.31
Neurosurgical implications of Carney complex. J Neurosurg (2000) 1.30
Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics (1995) 1.29
Hereditary multiple exostoses: from genetics to clinical syndrome and complications. Eur J Radiol (2001) 1.26
Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene. J Clin Endocrinol Metab (1993) 1.26
Carney complex: diagnosis and management of the complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas. Am J Med Genet (1998) 1.25
Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene family. Genomics (1998) 1.24
Delineation of a contiguous gene syndrome with multiple exostoses, enlarged parietal foramina, craniofacial dysostosis, and mental retardation, caused by deletions in the short arm of chromosome 11. Am J Hum Genet (1996) 1.23
A duplication in the L1CAM gene associated with X-linked hydrocephalus. Nat Genet (1993) 1.22
Pictorial essay. Myositis ossificans circumscripta. JBR-BTR (2003) 1.22
Genetic heterogeneity in Peutz-Jeghers syndrome. Hum Mutat (2000) 1.22
Transgenic mouse model for the fragile X syndrome. Am J Med Genet (1996) 1.22
The spectrum of mutations in UBE3A causing Angelman syndrome. Hum Mol Genet (1999) 1.21
Identification of mutations in the MSX2 homeobox gene in families affected with foramina parietalia permagna. Hum Mol Genet (2000) 1.20
Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21. Am J Hum Genet (1998) 1.20
Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest (1991) 1.18
Sclerosing bone dysplasias: genetic and radioclinical features. Eur Radiol (2000) 1.17
Identification and characterization of a novel member of the EXT gene family, EXTL2. Eur J Hum Genet (1998) 1.17
Nodular fasciitis: correlation of MRI findings and histopathology. Skeletal Radiol (2002) 1.16
Alternative splicing in the fragile X gene FMR1. Hum Mol Genet (1993) 1.16
Camurati-Engelmann disease. Review of radioclinical features. Acta Radiol (2003) 1.16
Mutations in FLNB cause boomerang dysplasia. J Med Genet (2005) 1.16
Genotype-phenotype correlation in L1 associated diseases. J Med Genet (1998) 1.16
The association of meningioma and pituitary adenoma: report of seven cases and review of the literature. Eur Neurol (1993) 1.16